[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335545-105":59,"doc-detail-335545-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","personalized-cancer-vaccine-design-using-ai-powered-technologies","Personalized cancer vaccine design using AI-powered technologies","","Immunotherapy ushers in a new era of cancer treatment, but cancer continues to cause extensive global mortality. Cancer vaccines activate immune responses to specifically target cancer cells, with therapeutic approaches increasingly focusing on tumor-associated antigens and neoantigens. This review examines how artificial intelligence accelerates epitope design, improves mRNA and DNA vaccine instruction optimization, and supports personalized vaccine strategies through prediction of patient responses. It also addresses remaining limitations including tumor heterogeneity, genetic variability, and unresolved ethical and regulatory issues around privacy and algorithmic bias, emphasizing interdisciplinary integration to advance responsible, effective personalized immunotherapies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/personalized-cancer-vaccine-design-using-ai-powered-technologies/335545/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/personalized-cancer-vaccine-design-using-ai-powered-technologies/335545.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main focus of this review?","Question",{"text":113,"@type":114},"The review focuses on how artificial intelligence can support personalized cancer vaccine design, including epitope design, optimization of nucleic-acid vaccine instructions, and prediction of patient responses.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do cancer vaccines work in general?",{"text":118,"@type":114},"Cancer vaccines aim to stimulate the immune system to recognize and attack tumor cells by targeting tumor antigens, generating specific and long-lasting immunity.",{"name":120,"@type":111,"acceptedAnswer":121},"What challenges limit current AI-powered neoantigen prediction?",{"text":122,"@type":114},"Key limitations include tumor heterogeneity and genetic variability, which can reduce the effectiveness of neoantigen prediction.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},335545,1790019749,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":4},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","TYPE Review  \nPUBLISHED 08 November 2024 DOI 10.3389/fimmu.2024.1357217  \nOPEN ACCESS  \nEDITED BY  \nAlexandre Barbosa Reis,  \nUniversidade Federal de Ouro Preto, Brazil  \nREVIEWED BY  \nZongguang Tai,  \nTongji University School of Medicine, China Ming Zheng,  \nAcademy of Military Medical Sciences (AMMS), China  \n*CORRESPONDENCE  \nDinakaran M  \n [dinakaran.m@vit.ac.in](dinakaran.m@vit.ac.in)  \n†These authors have contributed equally to this work and share ﬁrst authorship  \nRECEIVED 17 December 2023  \nACCEPTED 24 September 2024  \nPUBLISHED 08 November 2024  \nCITATION  \nKumar A, Dixit S, Srinivasan K, M D and Vincent PMDR (2024) Personalized  \ncancer vaccine design using AI-powered technologies.  \nFront. Immunol. 15:1357217 .  \ndoi: 10.3389/fimmu.2024.1357217  \nCOPYRIGHT  \n© 2024 Kumar, Dixit, Srinivasan, M and Vincent. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nPersonalized cancer vaccine design using AI-powered technologies  \nAnant Kumar 1†, Shriniket Dixit 2†, Kathiravan Srinivasan 2, Dinakaran M 3* and P. M. Durai Raj Vincent 4  \n1School of Bioscience and Technology, Vellore Institute of Technology, Vellore, India, 2School of Computer Science and Engineering, Vellore Institute of Technology, Vellore, India, 3School of Computer Science and Engineering, Vellore Institute of Technology, Chennai, India, 4School of Computer Science Engineering and Information Systems, Vellore Institute of Technology, Vellore, India  \nImmunotherapy has ushered in a new era of cancer treatment, yet cancer remains a leading cause of global mortality. Among various therapeutic strategies, cancer vaccines have shown promise by activating the immune system to speciﬁcally target cancer cells. While current cancer vaccines are primarily prophylactic, advancements in targeting tumor-associated antigens (TAAs) and neoantigens have paved the way for therapeutic vaccines. The integration of artiﬁcial intelligence (AI) into cancer vaccine development is revolutionizing the ﬁeld by enhancing various aspect of design and delivery. This review explores how AI facilitates precise epitope design, optimizes mRNA and DNA vaccine instructions, and enables personalized vaccine strategies by predicting patient responses. By utilizing AI technologies, researchers can navigate complex biological datasets and uncover novel therapeutic targets, thereby improving the precision and efﬁcacy of cancer vaccines. Despite the promise of AI-powered cancer vaccines, signiﬁcant challenges remain, such as tumor heterogeneity and genetic variability, which can limit the effectiveness of neoantigen prediction. Moreover, ethical and regulatory concerns surrounding data privacy and algorithmic bias must be addressed to ensure responsible AI deployment. The future of cancer vaccine development lies in the seamless integration of AI to create personalized immunotherapies that offer targeted and effective cancer treatments. This review underscores the importance of interdisciplinary collaboration and innovation in overcoming these challengesand advancing cancer vaccine development.  \nKEYWORDS  \ncancer vaccine, artiﬁcial intelligence, epitope design, neoantigen prediction, MHCpeptide binding prediction, nucleic acid cancer vaccines, peptide cancer vaccines, personalized cancer vaccine  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nCancer is a major global cause of death (1), responsible for around 10 million deaths in 2020 (2) . As one of the leading health challenges worldwide, it remains a critical area of research and innovation . Among the various treat","cbCaieZt2SJKnGqM","https://ap.wps.com/l/cbCaieZt2SJKnGqM","pdf",2918923,25,"English","# 1 Introduction\n# Cancer vaccines and therapeutic strategies\n# Role of AI in personalized cancer vaccine development\n# Challenges and future directions","[{\"question\":\"What is the main focus of this review?\",\"answer\":\"The review focuses on how artificial intelligence can support personalized cancer vaccine design, including epitope design, optimization of nucleic-acid vaccine instructions, and prediction of patient responses.\"},{\"question\":\"How do cancer vaccines work in general?\",\"answer\":\"Cancer vaccines aim to stimulate the immune system to recognize and attack tumor cells by targeting tumor antigens, generating specific and long-lasting immunity.\"},{\"question\":\"What challenges limit current AI-powered neoantigen prediction?\",\"answer\":\"Key limitations include tumor heterogeneity and genetic variability, which can reduce the effectiveness of neoantigen prediction.\"}]","Personalized cancer vaccine design using AI-powered technologies | PDF",1790011391,63]